Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeHealthy LivingDigestive HealthSabinsa Granted US Patent on Lactospore® for IBS

Sabinsa Granted US Patent on Lactospore® for IBS

Article-Sabinsa Granted US Patent on Lactospore® for IBS

<p>Sabinsa has been granted a US patent on the company's shelf-stable probiotic Lactospore&reg;&nbsp; for its use for therapeutic management or Irritable Bowel Syndrome (IBS).</p>
TAGS: Archive Probiotics & Prebiotics Healthy Living
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
Lallemand.jpg
Paid Content
S. boulardii: A time-tested yeast culture, mastered and perfected from lab to shelf – white paper
May 10, 2023
Alesco.jpg
Paid Content
Higher mineral absorption and tolerability with Sucrosomial® technology – white paper
May 04, 2023
SSN365_23_SponsorProgram_EduSeries-PoweredBy_1540x800 - NPI.png
SupplySide Education Series: Biotics in ingredients and finished products – webinar
May 03, 2023
Probiotics and the Microbiome
SupplySide East 2023 preview: How probiotics travel the gut/brain axis to affect mood and sleep
Apr 10, 2023